Jonathan Jay Mazelsky, President & CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 23,060 shares at $379.50 ($8.8M) on 2022-11-07, disclosed to the SEC on 2022-11-09.
Open-market sale of $8.8M IDXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $378.60 | 900 | $341K | 3.9% |
| 2 | $379.50 | 2,000 | $759K | 8.6% |
| 3 | $380.85 | 500 | $190K | 2.2% |
| 4 | $382.81 | 3,704 | $1.4M | 16.1% |
| 5 | $382.81 | 3,704 | $1.4M | 16.1% |
| 6 | $383.29 | 2,716 |
| $1.0M |
| 11.8% |
| 7 | $383.29 | 2,716 | $1.0M | 11.8% |
| 8 | $384.47 | 3,018 | $1.2M | 13.1% |
| 9 | $384.47 | 3,018 | $1.2M | 13.1% |
| 10 | $385.01 | 392 | $151K | 1.7% |
| 11 | $385.01 | 392 | $151K | 1.7% |
| Total | $382.94 avg | 23,060 | $8.8M | 100% |
| Filing → |
| IDXX | SELL | 2024-02-09 | $13.7M | — | Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |